Pancreatic cancer is one of the most fatal malignancies and the seventh leading cause of
cancer-related deaths related to late diagnosis, poor survival rates, and high incidence of …

The diagnosis of adenocarcinomas located in the pancreas head, ie, distal
cholangiocarcinoma (dCCA) and pancreatic ductal adenocarcinoma (PDAC), constitutes a …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant tumor types,
being the sixth leading cause of mortality worldwide and the fourth in Europe. Globally, it has …

Purpose Resistance to gemcitabine remains a key challenge in the treatment of pancreatic
ductal adenocarcinoma (PDAC), necessitating the constant search for effective strategies for …

Background: Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor with a high
mortality rate. PDAC exhibits significant heterogeneity as well as alterations in metabolic …

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest malignancies and
potentially curable only with radical surgical resection at early stages. The tumor …

Poor outcome of pancreatic cancer necessitates development of an early diagnostic method
to reduce mortality. No reliable early diagnostic test for pancreatic cancer detection has …

Simple Summary The survival of organic systems is dependent on metabolic conditions,
necessary for the proper functioning of all biological processes. Cancer takes advantage of …

Cancer heterogeneity remains a significant challenge for effective cancer treatments. Altered
energetics is one of the hallmarks of cancer and influences tumor growth and drug …

In this review, we discuss selected topics which are relevant to implementing precision
medicine in metabolic disorders. Personalization of diet and exercise may help in preventing …